A smartphone app designed to identify potential mistakes in medications for patients with chronic kidney disease (CKD) led to a 60% relative reduction in the incidence of discrepancies
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. AMARYL® (am-a(r)-RILL) glimepiride (glim-epi-RIDE) Consumer Medicine Information (CMI) What is in this leaflet This leaflet
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KYPROLIS® Carfilzomib (kar FILZ oh mib) Consumer Medicine Information (CMI) What is in this leaflet
TUESDAY, Aug. 14, 2018 — Older kidney failure patients on hemodialysis have high rates of dementia, which is associated with an increased risk of early death, a new
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
